Raül Rigo‐Bonnin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Renal Transplantation Outcomes and Treatments 15
-
- Antibiotic Use and Resistance 6
- Co-authors
- Pedro AlíaFé TubauAriadna PadullésÓscar MurilloEvelyn ShawFrancesca CanalíasJordi CarratalàHelena Colom
In The Last Decade
Raül Rigo‐Bonnin
69 papers receiving 722 citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 219
- Transplantation 104
- Applied Microbiology and Biotechnology 75
- Pharmacology 261
- Clinical Biochemistry 69
Countries citing papers authored by Raül Rigo‐Bonnin
This map shows the geographic impact of Raül Rigo‐Bonnin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raül Rigo‐Bonnin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raül Rigo‐Bonnin more than expected).
Fields of papers citing papers by Raül Rigo‐Bonnin
This network shows the impact of papers produced by Raül Rigo‐Bonnin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raül Rigo‐Bonnin. The network helps show where Raül Rigo‐Bonnin may publish in the future.
Co-authors
The 25 scholars most cited alongside Raül Rigo‐Bonnin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 5 | |
| 15 | 2020 | 7 | |
| 16 | Sugammadex 50 mg/5 ml allows clinicians rationalize its use for residual neuromuscular blockade reversal | 2017 | 1 |
| 17 | L'espectrometria de masses com a principi de mesura: fonaments i aplicació en les ciències de laboratori clínic | 2013 | 0 |
| 18 | La cromatografia com a principi de mesura: classificació, fonaments teòrics i aplicació en les ciències de laboratori clínic | 2013 | 0 |
| 19 | 2007 | 55 | |
| 20 | 2007 | 0 |
About Raül Rigo‐Bonnin
Raül Rigo‐Bonnin is a scholar working on Transplantation, Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 78 papers that have together received 741 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Renal Transplantation Outcomes and Treatments (15 papers), Antibiotic Resistance in Bacteria (13 papers), Pharmacological Effects and Toxicity Studies (12 papers), Clinical Laboratory Practices and Quality Control (8 papers), Pneumonia and Respiratory Infections (8 papers), Analytical Methods in Pharmaceuticals (6 papers) and Antibiotic Use and Resistance (6 papers). The work is most often cited by research in Molecular Medicine (219 citations), Transplantation (104 citations), Applied Microbiology and Biotechnology (75 citations), Pharmacology (261 citations) and Clinical Biochemistry (69 citations). Raül Rigo‐Bonnin has collaborated with scholars based in Spain, Germany and Belgium. Frequent co-authors include Pedro Alía, Fé Tubau, Ariadna Padullés, Óscar Murillo, Evelyn Shaw, Francesca Canalías, Jordi Carratalà, Helena Colom, Pablo Moreno and Eva Benavent. Their work appears in journals such as Clinica Chimica Acta, Clinical Biochemistry, International Journal of Antimicrobial Agents, Clinical Chemistry and Laboratory Medicine (CCLM) and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.